Publication | Closed Access

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

Elderly PatientsGastrointestinal OncologyMedicineCancer ManagementCapecitabine Versus CapecitabineClinical TrialsColorectal CancerMetastatic Colorectal CancerPharmacotherapyCancer TreatmentOncologyRadiation OncologyHealth Sciences